Mesoblast Limited (MESO)
Ryoncil Sales for the Quarter Increase 60% to US$35.1M
Ryoncil Sales for the Quarter Increase 60% to US$35.1M
Notification from CorMedix Inc.
CONMED Corporation Announces Chief Financial Officer Transition
QURE Investigation: Kessler Topaz Meltzer & Check, LLP Encourages uniQure N.V. (NASDAQ: QURE) Investors with Significant Losses to Contact the Firm
Praxis Precision Medicines Further Positioned for Next-Phase Growth with Key Board and Executive Appointments
Illumina, Inc. - Illumina Appoints Dr. Eric Green as Chief Medical Officer
Quanterix Appoints Everett Cunningham as President and CEO Effective January 19, 2026
Cellectis Announces 2026 Strategy and Catalysts
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026